METTL3 and ovarian carcinoma: METTL3 was previously reported as a tumor-promoting factor in ovarian cancer [13], in accordance with our present results that overexpression of METTL3 could accelerate proliferation, migration, and invasion, while inhibiting apoptosis of ovarian cancer cells.